
MicroPort Scientific Corp.
0853.HKHKSEHealthcareMedical - Devices
最新数据
HK$6.29
−HK$0.305 · -4.63%
0853.HK公司概览
盘中时间采用HKT。市场数据可能有所延迟。
公司概况
公司网站MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture, and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Devices Business, Cardiac Rhythm Management Business, Endovascular and Peripheral Vascular Devices Business, Neurovascular Devices Business, Surgical Devices Business, Heart Valve Business, Surgical Robot Devices Business, and Others. The Cardiovascular Devices Business segment offers integrated medical solutions for the treatment of coronary artery-related diseases, develops, manufactures, and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories and active devices, in fulfilling the overall demands of doctors and patients worldwide. The Orthopedics Devices Business segment is involved in the total solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments. The Cardiac Rhythm Management Business segment develops, manufactures, and markets of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, and cardiac resynchronization therapy devices. The Endovascular and Peripheral Vascular Devices Business segment focuses on providing integrated disease solutions for aortic and peripheral vascular diseases such as thoracic and abdominal aortic aneurysm, aortic dissection, atherosclerosis, and lower extremity arteriosclerotic occlusion. The Neurovascular Devices Business segment specializes in providing total solutions for the treatment of neurovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke, continuously focused on research and development, production and commercialization of neurovascular therapeutic and access devices. The Surgical Devices Business segment provides overall solutions for cardiac surgery and emergency life support. The Heart Valve Business segment includes sale, manufacture, research, and development of heart valve devices. The Surgical Robot Devices Business segment designs, develops, and commercializes innovative surgical robots. The company was founded by Zhao Hua Chang in 1998 and is headquartered in Shanghai, China.
- 行业
- Medical - Devices
- 部门
- Healthcare
- 总部
- CN
- 首席执行官
- Jonathan W. Chen
- 上市以来
- 2010年9月24日
- 雇员
- 6,547
市场位置
- 成交量
- 945.29万
- 0.76× 平均值
- 平均成交量
- 1246.91万
- 日均成交量
- 市值
- 120.22亿 HKD
- 贝塔
- 0.36
- 市场参考 1
财务数据
财务快照
最近十二个月估值与收益率
- 企业价值
- 35.21亿 USD
- 市盈率(TTM)
- 32.33×
- 市净率(TTM)
- 1.35×
- 市销率(TTM)
- 1.54×
- EV/EBITDA
- 39.63×
- 盈利收益率
- 1.87%
- 自由现金流收益率
- -2.99%
- 股息率
- 0.00%
盈利能力和效率
- 毛利率
- 55.18%
- 营业利润率
- -3.73%
- 净利润率
- 4.89%
- 净资产收益率
- 4.95%
- 资产收益率
- 1.31%
- 投入资本回报率
- -1.65%
财务健康
- 负债权益比
- 1.63×
- 流动比率
- 1.45×
财报历史与展望
- 最新财年每股收益
- 0.015
- 2025财年
- 最新财年收入
- 9.96亿 USD
- 2025财年 · 同比-3.36%
- 下一财年每股收益共识
- 0.05
- 2026财年 · 3位分析师
- 下一财年收入共识
- 11.93亿 USD
- 2026财年 · 7位分析师
年度每股收益趋势
已公布业绩及可用的市场共识预期。
年度营收趋势
已公布业绩及可用的市场共识预期。
0853.HK同业公司
持有0853.HK的ETF
报告持有此股票敞口的交易所交易基金。
Vanguard Total International Stock ETFVXUS1345.24万0.00%6462亿 USD0.05%US$87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO1337.12万0.01%1623亿 USD0.06%US$60.45+0.72%
iShares Core MSCI Emerging Markets ETFIEMG966万0.01%1600.01亿 USD0.09%US$81.57+0.64%
Vanguard FTSE All-World ex-US ETFVEU210.01万0.00%959亿 USD0.04%US$85.69+0.82%
iShares Core MSCI Total International Stock ETFIXUS149.86万0.00%609.08亿 USD0.07%US$97.945+0.76%
Schwab Emerging Markets Equity ETFSCHE114.19万0.01%128.93亿 USD0.06%US$36.97+0.71%
State Street SPDR Portfolio Emerging Markets ETFSPEM82.43万0.00%175.73亿 USD0.07%US$52.38+0.61%
Vanguard Total World Stock ETFVT77.48万0.00%979亿 USD0.06%US$160.77+0.53%
Vanguard Total International Stock ETFVXUS- 市场价值
- 1345.24万
- 重量
- 0.00%
- AUM
- 6462亿 USD
- 费用率
- 0.05%
- 价格 / 1日
- US$87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO- 市场价值
- 1337.12万
- 重量
- 0.01%
- AUM
- 1623亿 USD
- 费用率
- 0.06%
- 价格 / 1日
- US$60.45+0.72%
iShares Core MSCI Emerging Markets ETFIEMG- 市场价值
- 966万
- 重量
- 0.01%
- AUM
- 1600.01亿 USD
- 费用率
- 0.09%
- 价格 / 1日
- US$81.57+0.64%
Vanguard FTSE All-World ex-US ETFVEU- 市场价值
- 210.01万
- 重量
- 0.00%
- AUM
- 959亿 USD
- 费用率
- 0.04%
- 价格 / 1日
- US$85.69+0.82%
iShares Core MSCI Total International Stock ETFIXUS- 市场价值
- 149.86万
- 重量
- 0.00%
- AUM
- 609.08亿 USD
- 费用率
- 0.07%
- 价格 / 1日
- US$97.945+0.76%
Schwab Emerging Markets Equity ETFSCHE- 市场价值
- 114.19万
- 重量
- 0.01%
- AUM
- 128.93亿 USD
- 费用率
- 0.06%
- 价格 / 1日
- US$36.97+0.71%
State Street SPDR Portfolio Emerging Markets ETFSPEM- 市场价值
- 82.43万
- 重量
- 0.00%
- AUM
- 175.73亿 USD
- 费用率
- 0.07%
- 价格 / 1日
- US$52.38+0.61%
Vanguard Total World Stock ETFVT- 市场价值
- 77.48万
- 重量
- 0.00%
- AUM
- 979亿 USD
- 费用率
- 0.06%
- 价格 / 1日
- US$160.77+0.53%
继续GoAI的研究
在 GoAI 中研究0853.HKresearch.disclaimer





